Unavailable
Unavailable
Save time and jump to the most important pieces.
Date | Price Target | Rating | Analyst |
---|---|---|---|
2/11/2025 | $51.00 | Buy | Jefferies |
11/22/2024 | $40.00 | Outperform → Strong Buy | Raymond James |
7/2/2024 | $27.00 | Buy | BofA Securities |
7/2/2024 | $24.00 | Overweight | Barclays |
7/2/2024 | $27.00 | Buy | Deutsche Bank |
7/2/2024 | $32.00 | Buy | Goldman |
7/2/2024 | $24.00 | Overweight | JP Morgan |
7/2/2024 | $25.00 | Outperform | Evercore ISI |
Jefferies initiated coverage of Waystar Holding Corp. with a rating of Buy and set a new price target of $51.00
Raymond James upgraded Waystar Holding Corp. from Outperform to Strong Buy and set a new price target of $40.00
BofA Securities initiated coverage of Waystar Holding Corp. with a rating of Buy and set a new price target of $27.00
4 - Waystar Holding Corp. (0001990354) (Issuer)
Fiscal year 2024 revenue of $944M, up 19% YoY Q4 revenue growth of 18% year-over-year Q4 net income of $19.1 million and non-GAAP net income of $52.1 million Fiscal year 2024 net loss $19.1 million, 62.7% improvement YoY Fiscal year 2024 adjusted EBITDA of $383M, up 15% YoY Q4 net income margin of 8%; adjusted EBITDA margin of 41% LEHI, Utah and LOUISVILLE, Ky., Feb. 18, 2025 /PRNewswire/ -- Waystar Holding Corp. (NASDAQ:WAY), a provider of leading healthcare payment software, today reported results for the fourth quarter and full year ended December 31, 2024. "We are please
LEHI, Utah and LOUISVILLE, Ky., Jan. 28, 2025 /PRNewswire/ -- Waystar Holding Corp. (NASDAQ:WAY), a provider of leading healthcare payment software, announced today that it will report financial results for the fourth quarter and fiscal year ended December 31, 2024, before market open on Tuesday, February 18, 2025. The company will discuss its financial results on a conference call at 8:30 a.m. Eastern Time that same day. A live audio webcast of the conference call will be available on Waystar's investor relations website at https://investors.waystar.com/news-events/events. Th
Revenue growth of 22% year-over-year Net income of $5.4 million and non-GAAP net income of $25.3 million Net income margin of 2%; Adjusted EBITDA margin of 40% LEHI, Utah and LOUISVILLE, Ky., Nov. 6, 2024 /PRNewswire/ -- Waystar Holding Corp. (NASDAQ:WAY), a provider of leading healthcare payment software, today reported results for the three-month period ended September 30, 2024. "Waystar delivered another quarter of strong top-line growth," said Matt Hawkins, Chief Executive Officer of Waystar. "Our revenue reached $240 million, representing 22% year-over-year growth, an a
SC 13G - Waystar Holding Corp. (0001990354) (Subject)
SC 13G - Waystar Holding Corp. (0001990354) (Subject)
SC 13G - Waystar Holding Corp. (0001990354) (Subject)
424B7 - Waystar Holding Corp. (0001990354) (Filer)
EFFECT - Waystar Holding Corp. (0001990354) (Filer)
S-1MEF - Waystar Holding Corp. (0001990354) (Filer)
4 - Waystar Holding Corp. (0001990354) (Issuer)
4 - Waystar Holding Corp. (0001990354) (Issuer)
4 - Waystar Holding Corp. (0001990354) (Issuer)
92% of leaders rank AI and advanced automation as a key focus for overcoming industry challenges Patient Access and Claim Management emerge as the top RCM functions prioritized for automation investment LEHI, Utah and LOUISVILLE, Ky., March 4, 2025 /PRNewswire/ -- Waystar (NASDAQ:WAY), a provider of leading healthcare payment software, today announced the results of a comprehensive Qualtrics market survey identifying the top revenue cycle management (RCM) trends of 2025. The study surveyed 600 healthcare RCM, finance, and technology leaders from provider organizations of all types and sizes. The findings show that decision-makers are actively prioritizing AI and advanced automation to addres
Latest software innovation automates every step of the authorization submission process, reducing time by 70% and dramatically boosting auto-approval rates LEHI, Utah, and LOUISVILLE, Ky., Feb. 28, 2025 /PRNewswire/ -- Waystar (NASDAQ:WAY), a provider of leading healthcare payment software, today announced the launch of its Auth Accelerate solution, a major expansion of its advanced automation capabilities designed to streamline the prior authorization process from start to finish. Prior authorizations pose significant challenges across the healthcare spectrum. In response, p
The offering resulted in aggregate gross proceeds of USD920 million, of which EQT received c. USD393 millionNEW YORK, Feb. 24, 2025 /PRNewswire/ -- An affiliate of the fund known as EQT VIII ("EQT") is pleased to announce the completion of an underwritten public offering (the "Offering") of 23 million shares of common stock of Waystar Holding Corp. (NASDAQ:WAY) (the "Company") ("Shares") for aggregate gross proceeds of USD920 million. As part of the Offering, EQT sold c. 9.8 million Shares (and now holds c. 38.8 million Shares) and received gross proceeds of c. USD393 million. The remaining Shares sold in the Offering were sold by other stockholders of the Company. J.P. Morgan, Goldman Sachs